Once-daily valacyclovir to reduce the risk of transmission of genital herpes.

Abstract

BACKGROUND Nucleoside analogues against herpes simplex virus (HSV) have been shown to suppress shedding of HSV type 2 (HSV-2) on genital mucosal surfaces and may prevent sexual transmission of HSV. METHODS We followed 1484 immunocompetent, heterosexual, monogamous couples: one with clinically symptomatic genital HSV-2 and one susceptible to HSV-2. The partners with HSV-2 infection were randomly assigned to receive either 500 mg of valacyclovir once daily or placebo for eight months. The susceptible partner was evaluated monthly for clinical signs and symptoms of genital herpes. Source partners were followed for recurrences of genital herpes; 89 were enrolled in a substudy of HSV-2 mucosal shedding. Both partners were counseled on safer sex and were offered condoms at each visit. The predefined primary end point was the reduction in transmission of symptomatic genital herpes. RESULTS Clinically symptomatic HSV-2 infection developed in 4 of 743 susceptible partners who were given valacyclovir, as compared with 16 of 741 who were given placebo (hazard ratio, 0.25; 95 percent confidence interval, 0.08 to 0.75; P=0.008). Overall, acquisition of HSV-2 was observed in 14 of the susceptible partners who received valacyclovir (1.9 percent), as compared with 27 (3.6 percent) who received placebo (hazard ratio, 0.52; 95 percent confidence interval, 0.27 to 0.99; P=0.04). HSV DNA was detected in samples of genital secretions on 2.9 percent of the days among the HSV-2-infected (source) partners who received valacyclovir, as compared with 10.8 percent of the days among those who received placebo (P<0.001). The mean rates of recurrence were 0.11 per month and 0.40 per month, respectively (P<0.001). CONCLUSIONS Once-daily suppressive therapy with valacyclovir significantly reduces the risk of transmission of genital herpes among heterosexual, HSV-2-discordant couples.

0100200'05'07'09'11'13'15'17
Citations per Year

1,524 Citations

Semantic Scholar estimates that this publication has 1,524 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Corey2004OncedailyVT, title={Once-daily valacyclovir to reduce the risk of transmission of genital herpes.}, author={Lawrence Corey and Anna Wald and Raj Patel and Stephen L. Sacks and Stephen Keith Tyring and Terri J Warren and John M . Douglas and Jorma Paavonen and Rhoda L Ashley Morrow and Karl R. Beutner and Leonid S Stratchounsky and Gr{\'e}gory Mertz and Oliver N. Keene and Helen A Watson and Dereck R Tait and Mauricio Vargas-Cortes}, journal={The New England journal of medicine}, year={2004}, volume={350 1}, pages={11-20} }